Why We Need To Talk About Psychedelic Dispensaries
Dispensaries could fill the regulatory void for psychedelics and promote public health.
A Roadmap to Reimbursement for Psychedelics
Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.
Branching Regulatory Paths and Dead Ends in Psychedelics
The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.
Administrative Law Essay Competition Winners
Two essays by the student winners of a Penn Carey Law essay competition describe important regulatory issues.
FDA’s Minimal Authority over Dietary Supplements
Scholars urge Congress to give FDA more power to regulate dietary supplements.
Cutting Corners on COVID-19 Treatments?
Scholars analyze FDA’s emergency use authorizations during the COVID-19 pandemic.
Supplementing Dietary Supplement Regulation
Experts recommend measures to improve the regulation of dietary supplements.
Patching Up Medical Device Cybersecurity Regulation
Researchers explore the optimal cost-benefit considerations of medical device cybersecurity risks.
Regulating Speech About a Drug’s Off-Label Uses
Scholar argues that FDA should adopt an evidenced-based approach to regulating drug manufacturers’ speech.
Protecting Medical Privacy on Your Wrist
Scholar argues for greater privacy protections of personal medical data collected by wearable health technologies.
Should USDA Regulate Lab-Grown Meat?
Scholar argues that FDA should be the sole regulator of cell-cultured meat.
Cracking Down on Overdose Deaths
FDA approves first over-the-counter treatment to combat the opioid overdose epidemic.